EVDIX | MERFX | EVDIX / MERFX | |
Total Expense Ratio | 1.77 | 1.56 | 113% |
Annual Report Gross Expense Ratio | 1.84 | 1.67 | 110% |
Fund Existence | 15 years | 37 years | - |
Gain YTD | 8.116 | 5.834 | 139% |
Front Load | N/A | 6% | - |
Min. Initial Investment | 1000000 | 2500 | 40,000% |
Min. Initial Investment IRA | N/A | N/A | - |
Net Assets | 97.2M | 2.39B | 4% |
Annual Yield % from dividends | 1.14 | 1.65 | 69% |
Returns for 1 year | 7.89 | 5.24 | 151% |
Returns for 3 years | -0.37 | 9.20 | -4% |
Returns for 5 years | 58.48 | 10.48 | 558% |
Returns for 10 years | 83.37 | 24.85 | 336% |
1 Day | |||
---|---|---|---|
MFs / NAME | Price $ | Chg $ | Chg % |
SHPCX | 12.71 | 0.09 | +0.71% |
Saratoga Health & Biotechnology C | |||
GCINX | 15.50 | 0.06 | +0.39% |
Green Century MSCI Intl Indx Indvl Inv | |||
FCUEX | 20.32 | 0.03 | +0.15% |
NYLI PineStone U.S. Equity Class A | |||
OEGAX | 28.68 | -0.07 | -0.24% |
Invesco Discovery Mid Cap Growth A | |||
MUSBX | 36.64 | -0.13 | -0.35% |
MFS Blended Research Core Equity B |